Clinical Oncology NGS Market Thrives with Precisio..

Nouvel article créé

Traduire 8 jours depuis

Clinical Oncology NGS Market Thrives with Precision Medicine and Cancer Genomics Advancements | #clinical Oncology Next Generation Sequencing Market

Clinical Oncology NGS Market Thrives with Precision Medicine and Cancer Genomics Advancements

Data Bridge Market Research analyses that the clinical oncology next generation sequencing market which was USD 592.56 million in 2021, would rocket up to USD 1825.30 million by 2029, and is expected to undergo a CAGR of 15.1% during the forecast period 2022 to 2029.

Clinical Oncology NGS Market Thrives with Precision Medicine and Cancer Genomics Advancements

Aimer

Commentaire

Partagez

640